BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7915525)

  • 1. Family screening in multiple endocrine neoplasia type 1 (MEN 1).
    Larsson C; Nordenskjöld M
    Ann Med; 1994 Jun; 26(3):191-8. PubMed ID: 7915525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic aspects of multiple endocrine neoplasia types 1 and 2.
    Sandelin K; Larsson C; Decker RA
    Curr Opin Gen Surg; 1994; ():60-8. PubMed ID: 7584011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical guidelines for DNA-based testing in multiple endocrine neoplasia type 1.
    Larsson C; Nordenskjold M; Skogseid B; Oberg K
    Henry Ford Hosp Med J; 1992; 40(3-4):173-6. PubMed ID: 1362400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms.
    Larsson C; Shepherd J; Nakamura Y; Blomberg C; Weber G; Werelius B; Hayward N; Teh B; Tokino T; Seizinger B
    J Clin Invest; 1992 Apr; 89(4):1344-9. PubMed ID: 1348254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of the genetic defect in multiple endocrine neoplasia type 1 within a small region of chromosome 11.
    Nakamura Y; Larsson C; Julier C; Byström C; Skogseid B; Wells S; Oberg K; Carlson M; Taggart T; O'Connell P
    Am J Hum Genet; 1989 May; 44(5):751-5. PubMed ID: 2565085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and clinical characteristics of multiple endocrine neoplasia type 1.
    Skogseid B; Larsson C; Oberg K
    Acta Oncol; 1991; 30(4):485-8. PubMed ID: 1677252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic testing in presymptomatic diagnosis of multiple endocrine neoplasia.
    Calender A; Giraud S; Schuffenecker I; Lenoir GM; Gaudray P; Courseaux A; Porchet N; Aubert JP; Zhang CX
    Horm Res; 1997; 47(4-6):199-210. PubMed ID: 9167953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11.
    Thakker RV; Bouloux P; Wooding C; Chotai K; Broad PM; Spurr NK; Besser GM; O'Riordan JL
    N Engl J Med; 1989 Jul; 321(4):218-24. PubMed ID: 2568587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma.
    Larsson C; Skogseid B; Oberg K; Nakamura Y; Nordenskjöld M
    Nature; 1988 Mar; 332(6159):85-7. PubMed ID: 2894610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presymptomatic screening for multiple endocrine neoplasia type 2A with linked DNA markers. The MEN 2A International Collaborative Group.
    Mathew CG; Easton DF; Nakamura Y; Ponder BA
    Lancet; 1991 Jan; 337(8732):7-11. PubMed ID: 1670689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic screening to identify the gene carrier in Italian and German kindreds affected by multiple endocrine neoplasia type 1 (MEN 1) syndrome.
    Morelli A; Falchetti A; Castello R; Furlani L; Tomassetti P; Tonelli F; Frilling A; Serio M; Brandi ML
    J Endocrinol Invest; 1995 May; 18(5):329-35. PubMed ID: 7594219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linked markers flanking the gene for multiple endocrine neoplasia type 2A.
    Nakamura Y; Mathew CG; Sobol H; Easton DF; Telenius H; Bragg T; Chin K; Clark J; Jones C; Lenoir GM
    Genomics; 1989 Aug; 5(2):199-203. PubMed ID: 2571570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multiple endocrine neoplasia type 1 (MEN 1). Molecular genetics, morphology and prognosis].
    Schröder S; Padberg B; Capella C; Frilling A; Klöppel G; Heitz PU
    Pathologe; 1994 Jun; 15(3):150-7. PubMed ID: 7915416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of MEN 203 as a polymorphic DNA probe in screening multiple endocrine neoplasia 2a.
    Kojima K; Totsuka Y
    Endocrinol Jpn; 1991 Dec; 38(6):583-7. PubMed ID: 1688047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linkage analysis of a DNA marker localized to 20p12 and multiple endocrine neoplasia type 2A.
    Goodfellow PJ; White BN; Holden JJ; Duncan AM; Sears EV; Wang HS; Berlin L; Kidd KK; Simpson NE
    Am J Hum Genet; 1985 Sep; 37(5):890-7. PubMed ID: 2864854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetics of multiple endocrine neoplasia (MEN).
    Calender A; Schuffenecker I; Lenoir GM
    Horm Res; 1992; 38 Suppl 2():16-23. PubMed ID: 1363412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linkage analysis of 7 polymorphic markers at chromosome 11p11.2-11q13 in 27 multiple endocrine neoplasia type 1 families.
    Thakker RV; Wooding C; Pang JT; Farren B; Harding B; Anderson DC; Besser GM; Bouloux P; Brenton DP; Buchanan KD
    Ann Hum Genet; 1993 Jan; 57(1):17-25. PubMed ID: 8101435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity of markers on chromosome 11 in tumors from patients with multiple endocrine neoplasia syndrome type 1.
    Radford DM; Ashley SW; Wells SA; Gerhard DS
    Cancer Res; 1990 Oct; 50(20):6529-33. PubMed ID: 1976436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublocalization of the multiple endocrine neoplasia type 1 gene.
    Larsson C; Weber G; Janson M
    Henry Ford Hosp Med J; 1992; 40(3-4):159-61. PubMed ID: 1362396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping eight new polymorphisms in 11q13 in the vicinity of multiple endocrine neoplasia type 1: identification of a new distal recombinant.
    Smith CM; Wells SA; Gerhard DS
    Hum Genet; 1995 Oct; 96(4):377-87. PubMed ID: 7557957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.